Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA5 | P31644 | 6/20 | 0.34 |
| ▸ | CFTR | P13569 | 3/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25116231 | 1.00 | GABRA5 (0.34) | GABRA5CFTRPOLBKMT2A | |
| SCHEMBL24985910 | 0.91 | CFTR (0.33) | GABRA5CFTRPOLBKMT2A | |
| SCHEMBL24985908 | 0.91 | CFTR (0.33) | GABRA5CFTRPOLBKMT2A | |
| SCHEMBL23905748 | 0.90 | GABRA5 (0.34) | GABRA5CFTR | |
| SCHEMBL23905753 | 0.90 | GABRA5 (0.34) | GABRA5CFTR | |
| SCHEMBL23905751 | 0.90 | GABRA5 (0.34) | GABRA5CFTR | |
| SCHEMBL24985779 | 0.90 | CFTR (0.33) | GABRA5CFTRPOLBKMT2A | |
| SCHEMBL24985771 | 0.90 | CFTR (0.33) | GABRA5CFTRPOLBKMT2A | |
| SCHEMBL24986097 | 0.90 | CFTR (0.35) | GABRA5CFTRPOLBKMT2A | |
| SCHEMBL24986096 | 0.90 | CFTR (0.35) | GABRA5CFTRPOLBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230108803-A1 | ANTIVIRAL HETEROCYCLIC COMPOUNDS | ENANTA PHARMACEUTICALS, INC. | 2023-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230108803-A1 | ANTIVIRAL HETEROCYCLIC COMPOUNDS | ACE, HPRT1, ACE2 | GABRA5 3773/4885CFTR 283/4885POLB 2743/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.